Role of anti-β2 glycoprotein I antibodies in antiphospholipid syndrome: In vitro and in vivo studies

Clinical Reviews in Allergy and Immunology

Volumn 32, Issue 1, 2007, Pages 67-73

  Meroni, Pier Luigi ^a   Ronda, Nicoletta ^b   De Angelis, Valentina ^a   Grossi, Claudia ^a   Raschi, Elena ^a   Borghi, Maria Orietta ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Antiphospholipid antibodies; Endothelial cells; Monocytes; Platelets; Trophoblast; 2 glycoprotein I

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; PHOSPHOLIPID ANTIBODY; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1;

ANTIBODY PRODUCTION; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; CELL FUNCTION; CELL MEMBRANE; CELL TYPE; CLINICAL FEATURE; CONFERENCE PAPER; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; HUMAN; MONOCYTE; NONHUMAN; RECURRENT ABORTION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOSIS; TROPHOBLAST; VEIN THROMBOSIS; ANIMAL; IMMUNOLOGY; REVIEW;

ANIMALS; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CELL MEMBRANE; ENDOTHELIAL CELLS; HUMANS;

EID: 85047700006     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02686083     Document Type: Conference Paper

References (49)

1. Fischetti, F., Durigutto, P., Pellis, V., et al. (2005), Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. Blood 106, 2340-2346.
2. Miyakis, S., Giannakopoulos, B., and Krilis, S. A. (2004), Beta 2 glycoprotein I-function in health and disease. Thromb Res 114, 335-346.
3. Rand, J., Eerden, P. V., Wu, X. X., and Chazotte, C. (2005), Defective annexin A5 crystallization: a mechanism for pregnancy losses in the antiphospholipid syndrome. Thromb Res 115, 77-81.
4. deLaat, B., Derksen, R. H., Urbanus, R. T., and de Groot, P. G. (2005), IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 105, 1540-1545.
5. Meroni, P. L., Raschi, E., Testoni, C., and Borghi, M. O. (2004). Endothelial cell activation by antiphospholipid antibodies. Clin Immunol 112, 169-174.
6. Pierangeli, S. S., Vega-Ostertag, M., and Harris, E. N. (2004), Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies. Thromb Res 114, 467-476.
7. de Groot, P. G., van Lummel, M., Pennings, M., et al. (2004), B2-Glycoprotein I and LDL-receptor family members. Thromb Res 114, 455-459.
8. 2glycoprotein I to human endothelial cells is mediated by Annexin II. J Biol Chem 275, 15,541-15,548.
9. 2Glycoprotein I antibodies. Blood 105, 1964-1969.
10. Raschi, E., Testoni, C., Bosisio, D., et al. (2003), Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 101, 3495-3500.
11. 2GPI) antibodies is mediated by annexin II cross linking and may involve TLR4. Blood 104 [abstract], 83.
12. Pierangeli, S. S., Colden-Stanfield, M., Liu, X., Barker, J. H., Anderson, G. H., and Harris, E. N. (1999). Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 99, 1997-2000.
13. Kaplanski, G., Cacoub, P., Farnarier, C., et al. (2000), Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis. Arthritis Rheum 43, 55-64.
14. Frijns, C. J., Derksen, R. H., De Groot, P. G., Algra, A., and Fijnheer, R. (2001), Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus. Clin Exp Immunol 125, 149-154.
15. Williams, F. M., Parmar, K., Hughes, G. R., and Hunt, B. J. (2000), Systemic endothelial cell markers in primary antiphospholipid syndrome. Thromb Haemostasis 84, 742-746.
16. Stalc, M., Poredos, P., Peternel, P., Tomsic, M., Sebestjen, M., and Kveder, T. (2006), Endothelial function is impaired in patients with primary antiphospholipid syndrome. Thromb Res118, 455-461.
17. Mercanoglu, F., Erdogan, D., Oflaz, H., et al. (2004), Impaired brachial endothelial function in patients with primary anti-phospholipid syndrome. Int J Clin Prac 58, 1003-1007.
18. Ventura, D., Borghi, M. O., Gerosa, M., et al. (2006), Antiphospholipid antibodies and ex-vivo endothelial perturbation, Abstract, First Joint Meeting of European Societies of Immunology, 16 th European Congress of Immunology.
19. Cuadrado, M. J., Lopez-Pedrera, C., Khamashta, M. A., et al. (1997), Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. Arthritis Rheum 40, 834-841.
20. Amengual, O., Atsumi, T., Khamashta, M. A., and Hughes, G. R. V. (1998), The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemostasis 79, 276-281.
21. Dobado-Barrios, M., L - pez-Perrara, C., Velasco, F., Aguirre, M. A., Torres, A., and Cuadrado, M. J. (1999), Increased levels of TF mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome. Thromb Haemostasis 82, 1578-1582.
22. Forestiero, R. R., Martinuzzo, M. E., and De Larranaga, G. (2005), Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprous related antiphospholipid antibodies. Lupus 14, 129-136.
23. Kornberg, A., Blank, M., Kaufman, S., and Shoenfeld, Y. (1994), Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J Immunol 153, 1328-1332.
24. Reverter, J. C., Tassies, D., Font, J., et al. (1998), Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. Arthritis Rheum 41, 1420-1427.
25. Zhou, H., Woldberg, A. S., and Roubey, R. A. (2004), Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood 104, 2353-2358.
26. Kinev, A. V., Shaw, M., Wu, J. L., and Roubey, R. A. S. (2005), Gene Expression Induced by Antiphospholipid Antibodies: Upregulation of Early Growth Response Genes and Certain Cytokines in Monocytic Cells. Arthritis Rheum 52, s611.
27. Lopez-Pedrera, C., Buendia, P., Cuadrado, M. J., et al. (2006), Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway. Arthritis Rheum 54, 301-311.
28. Vega-Ostertag, M., Harris, E. N., and Pierangeli, S. S. (2004), Intracellular Events in Platelet Activation Induced by Antiphospholipid Antibodies in the Presence of Low Doses of Thrombin. Arthritis Rheum 50, 2911-2619.
29. 2glycoprotein I for ApoER2′ on platelets is located in domain V. J Biol Chem 280, 36,729-36,736.
30. Out, H. J., Kooijman, C. D., Bruinse, H. W., and Derksen, R. H. (1991), Histopathological findings in placentae from patients with intra-uterine fetal death and antiphospholipid antibodies. Eur J Obstet Gynecol Reprod Biol 41, 179-186.
31. Sebire, N. J., Fox, H., Backos, M., Rai, R., Paterson, C., and Regan, L. (2002), Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum. Reprod. 17, 1067-1071.
32. Lyden, T. W., Vogt, E., Ng, A. K., Johnson, P. M., and Rote, N. S. (1992), Monoclonal antiphospholipid antibody reactivity against human placental trophoblast. J Reprod Immunol 22, 1-14.
33. Sthoeger, Z. M., Mozes, E., and Tartakovsky, B. (1993), Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Nat Acad Sci Online USA 90, 6464-6467.
34. Di Simone, N., Meroni, P. L., Del Papa, N., et al. (2000), Antiphospholipid antibodies affect trophoblast gonadotrophin secretion and invasiveness by binding directly and through adhered β2-glycoprotein I. Arthritis Rheum 43, 140-150.
35. Ornoy, A., Yacobi, S., Matalon, S. T., et al. (2003), The effects of antiphospholipid antibodies obtained from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture. Lupus 12, 573-578.
36. McIntyre J. A. (1992), Immune recognition at the maternal-fetal interface: overview. Am J Reprod Immunol 28, 127-131.
37. Chamley, L. W., Duncalf, A. M., Mitchell, M. D., and Johnson, P. M. (1998), Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet 352, 1037-1038.
38. Blank, M., Cohen, J., Toder, V., and Shoenfeld, Y. (1991), Induction of primary anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci Online USA 88, 3069-3073.
39. Ikematsu, W., Luan, F. L., La Rosa, L., et al. (1998), Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice. Arthritis Rheum 41, 1026-1039.
40. Di Simone, N., Castellani, R., Calandro, D., and Caruso, A. (2002), Antiphospholipid antibodies regulate the expression of trophoblast cell adhesion molecules. Fertility Sterility 77, 805-811.
41. Aplin, J. D., Haigh, T., Lacey, H., Chen, C. P., and Jones, C. J. (2000), Tissue interactions in the control of trophoblast invasion. J Reprod Fertil 55[Suppl], 57-64.
42. Bose, P., Black, S., Kadyrov, M., et al. (2004), Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro. Am J Obstetrics Gynecol 191, 2125-2131.
43. Matalon, S. T., Shoenfeld, Y., Blank, M., Yacobi, S., von Landenberg, P., and Ornoy, A. (2004), Antiphosphatidylserine antibodies affect rat yolk sacs in culture: a mechanism for fetal loss in antiphospholipid syndrome. Am J Reprod Immunol 51, 144-151.
44. Di Simone, N., Castellani, R., Raschi, E., Borghi, M. O., Meroni, P. L., and Caruso, A. (2006), Anti-beta2 glycoprotein I antibodies affect Bcl-2 and Bax trophoblast expression without evidence of apoptosis. Ann NY Acad Sci 1069, 364-376.
45. La Rosa, L., Meroni, P. L., Tincani, A., et al. (1994). β2-glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. J Rheumatol 21, 1684-1693.
46. Di Simone, N., Meroni, P. L., D'Asta, M., Di Nicuolo, F., D'Alessio, M. C., Caruso, A. (2005), Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro. Ann Rheum Dis 64, 462-467.
47. Kristoffersen, E. K. and Matre, R. (1996), Surface annexin II on placental membranes of the fetomaternal interface. Am J Reprod Immunol 36, 141-149.
48. Kim, DH., Iijima, H., Goto, K., et al. (1996), Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J Biol Chem 271, 8373-8380.
49. Miyakis, S., Lockshin, M. D., Atsumi, T., et al. (2006), International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemostasis 4, 295-306.